Evidence map›Paper›PMID 27626431›Full record

ArticleMarine drugs2016

R-Phycoerythrin Induces SGC-7901 Apoptosis by Arresting Cell Cycle at S Phase.

Huixin Tan, Shiyong Gao, Yan Zhuang, Yanhong Dong, Wenhui Guan, Kun Zhang, Jian Xu, Jingru Cui

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. MHBStVirology journal · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Propofol activates AMPK to inhibit the growth of HepG2 cellsJournal of gastrointestinal oncology · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Huixin TanDepartment of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China. thxydsy@163.com.
Shiyong GaoThe Institute of Materia Medica, The Research Center of Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin 150076, China. sygao2002@163.com.
Yan ZhuangThe Institute of Materia Medica, The Research Center of Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin 150076, China. zzyilai@163.com.
Yanhong DongDepartment of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China. dyhhrb@163.com.
Wenhui GuanDepartment of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China. guanwxydsy@163.com.
Kun ZhangDepartment of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China. zhangkunydsy@163.com.
Jian XuDepartment of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China. xujianydsy@163.com.
Jingru CuiDepartment of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China. cuijr2016@163.com.
Fourth Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNHarbin University of Commerce · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

R-Phycoerythrin (R-PE), one of the chemical constituents of red algae, could produce singlet oxygen upon excitation with the appropriate radiation and possibly be used in photodynamic therapy (PDT) for cancer. Documents reported that R-PE could inhibit cell proliferation in HepG2 and A549 cells, which was significative for cancer therapy. This is due to the fact that R-PE could kill cancer cells directly as well as by PDT. However, little is known about the cytotoxicity of R-PE to the SGC-7901 cell. In this study, it has been found that R-PE could inhibit SGC-7901 proliferation and induce cell apoptosis, which was achieved by arresting the SGC-7901 cell at S phase. CyclinA, CDK2 and CDC25A are proteins associated with the S phase, and it was found that R-PE could increase the expression of cyclin A protein and decrease the expression of CDK2 and CDC25A proteins. Thus, it was concluded that R-PE reduced the CDK2 protein activated through decreasing the CDC25A factor, which reduced the formation of Cyclin-CDK complex. The reduction of Cyclin-CDK complex made the SGC-7901 cells arrest at the S phase. Therefore, R-PE induced apoptosis by arresting the SGC-7901 cell at S phase was successful, which was achieved by the expression of the CDC25A protein, which reduced the CDK2 protein actived and the formation of Cyclin-CDK complex.

Indexed as

Apoptosiscdc25 PhosphatasesCell Cycle CheckpointsCell Cycle ProteinsCell Line, TumorCell ProliferationCell SurvivalCyclin ACyclin-Dependent Kinase 2HumansPhycoerythrinS PhaseCDC25A protein, humancdc25 PhosphatasesCDK2 protein, humanCell Cycle ProteinsCyclin ACyclin-Dependent Kinase 2Phycoerythrinapoptosiscell cycle arrestcell cycle-related proteinhuman gastric cancerR-phycoerythrin

Identifiers

PMID27626431
PMCPMC5039537
OpenAlexW2519098629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.